# Vaccines and Related Biological Products Advisory Committee (VRBPAC)

Type: Company

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/vaccines-and-related-biological-products-advisory-committee-vrbpac
Canonical HTML page: https://gethealthbrief.com/entity/vaccines-and-related-biological-products-advisory-committee-vrbpac

## Recent coverage (1 stories)

### FDA Approves First mRNA Flu Shot, Backed by 40,805-Patient Trial, for Adults 50+
2026-08-06 04:49:25 · Sentiment: Strongly positive · Impact: 7/10 · Sources: 2

The FDA has approved Moderna's mFLUSIVA, the first mRNA-based flu vaccine, for all adults 50 and older. The decision, based on a Phase 3 study enrolling 40,805 participants, introduces a new tool for a demographic disproportionately affected by severe influenza. Healthcare providers and public health agencies now have a potentially more adaptable option that could reshape seasonal vaccination campaigns.
Full story: https://gethealthbrief.com/story/moderna-mflusiva-fda-approval-health

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.